MetaCap

Carlsmed (CARL) vs Tactile Systems Technology (TCMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Carlsmed (CARL) has outperformed Tactile Systems Technology (TCMD) over the past year, gaining 39.5% versus a loss of 0.4%. Tactile Systems Technology is the larger company by market cap ($573.5 million vs $477.4 million), about 1.2 times the size, while Carlsmed is growing revenue faster (+85.9% vs +12.5%). Tactile Systems Technology converts more of its revenue into profit, with a net margin of 5.8% versus -58.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CARL+39.47%TCMD-0.39%
+53%+10%-33%
Nov 21, 20251 yearNov 20, 2026
CARL+20.14%TCMD+142.65%
+209%+79%-50%
Jul 21, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CARL versus TCMD key metrics
MetricCARLTCMD
Share price$17.42$25.60
Market cap$477.38M$573.48M
1-day change+1.16%-1.50%
YTD return+41.05%-11.72%
1-year return+39.47%-0.39%
5-year return—+23.85%
P/E ratio (TTM)—24.85
Forward P/E—17.41
EPS (TTM)$-1.13$1.03
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$50.51M$329.52M
Revenue growth (YoY)+85.94%+12.47%
Net income (latest FY)$-29.63M$19.09M
Gross margin75.31%75.91%
Operating margin-60.53%8.89%
Net margin-58.67%5.79%
52-week high$19.15$37.77
52-week low$8.50$20.53
Distance from 52-week high-9.05%-32.22%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+26.29%+41.91%
Average volume112.80K248.63K
Shares outstanding27.40M22.40M
Employees1271,086
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CARL has outperformed TCMD by 39.9 percentage points over the past year.
  • Tactile Systems Technology is more profitable, keeping 5.8 cents of every revenue dollar as net income versus -58.7 cents for Carlsmed.
  • Carlsmed grew revenue faster in its latest fiscal year (+85.94% vs +12.47%).

About Carlsmed

CARL stock →

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Health Care · Medical/Dental Instruments · 127 employees

About Tactile Systems Technology

TCMD stock →

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.

Health Care · Medical/Dental Instruments · 1,086 employees

CARL vs TCMD FAQ

Which is bigger, Carlsmed or Tactile Systems Technology?

Tactile Systems Technology (TCMD) is larger, with a market capitalization of $573.48M compared with $477.38M for Carlsmed (CARL).

Which stock has performed better over the past year, CARL or TCMD?

CARL returned +39.47% over the past 12 months, compared with -0.39% for TCMD (price return, excluding dividends). Past performance does not predict future results.

Are Carlsmed and Tactile Systems Technology in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons